Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hyaluronic Acid Gels for Upper Lid Retraction in Active TED
NCT01738243Phase 4Terminated
- Sponsor
- University of California, Los Angeles
- Start
- Dec 2013
- Primary completion
- Sep 2021
- Modality
- Hydrogel Systems
- Countries
- 1
01
Overview
A Phase 4 trial of hyaluronic acid sodium composite gel for injection in thyroid eye disease (TED), sponsored by University of California, Los Angeles. Started Dec 2013; status: terminated.
02
Drugs
hyaluronic acid sodium composite gel for injection
03
Conditions
thyroid eye disease (TED)
Beyond the preview
Go deeper on NCT01738243.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01738243.